Literature DB >> 11941484

A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25.

Mirna Mustapha1, Eliane Chouery, Delphine Torchard-Pagnez, Sylvie Nouaille, Awni Khrais, Fouad N Sayegh, André Mégarbané, Jacques Loiselet, Mark Lathrop, Christine Petit, Dominique Weil.   

Abstract

Usher syndrome (USH) is an autosomal recessive disorder associated with sensorineural hearing impairment and progressive visual loss attributable to retinitis pigmentosa. This syndrome is both clinically and genetically heterogeneous. Three clinical types have been described of which type I (USH1) is the most severe. Six USH1 loci have been identified. We report a Palestinian consanguineous family from Jordan with three affected children. In view of the combination of profound hearing loss, vestibular dysfunction, and retinitis pigmentosa in the patients, we classified the disease as USH1. Linkage analysis excluded the involvement of any of the known USH1 loci. A genome-wide screening allowed us to map this novel locus, USH1G, in a 23-cM interval on chromosome 17q24-25. The USH1G interval overlaps the intervals for two dominant forms of isolated hearing loss, namely DFNA20 and DFNA26. Since several examples have been reported of syndromic and isolated forms of deafness being allelic, USH1G, DFNA20, and DFNA26 might result from alterations of the same gene. Finally, a mouse mutant, jackson shaker ( js), with deafness and circling behavior has been mapped to the murine homologous region on chromosome 11.

Entities:  

Mesh:

Year:  2002        PMID: 11941484     DOI: 10.1007/s00439-002-0690-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle.

Authors:  Batiste Boëda; Aziz El-Amraoui; Amel Bahloul; Richard Goodyear; Laurent Daviet; Stéphane Blanchard; Isabelle Perfettini; Karl R Fath; Spencer Shorte; Jan Reiners; Anne Houdusse; Pierre Legrain; Uwe Wolfrum; Guy Richardson; Christine Petit
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

2.  Mutations of human TMHS cause recessively inherited non-syndromic hearing loss.

Authors:  M I Shabbir; Z M Ahmed; S Y Khan; Saima Riazuddin; A M Waryah; S N Khan; R D Camps; M Ghosh; M Kabra; I A Belyantseva; T B Friedman; Sheikh Riazuddin
Journal:  J Med Genet       Date:  2006-02-03       Impact factor: 6.318

Review 3.  New treatment options for hearing loss.

Authors:  Ulrich Müller; Peter G Barr-Gillespie
Journal:  Nat Rev Drug Discov       Date:  2015-03-20       Impact factor: 84.694

4.  Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes.

Authors:  Daniel Gibbs; Sassan M Azarian; Concepcion Lillo; Junko Kitamoto; Adriana E Klomp; Karen P Steel; Richard T Libby; David S Williams
Journal:  J Cell Sci       Date:  2004-11-30       Impact factor: 5.285

Review 5.  Usher protein functions in hair cells and photoreceptors.

Authors:  Dominic Cosgrove; Marisa Zallocchi
Journal:  Int J Biochem Cell Biol       Date:  2013-11-12       Impact factor: 5.085

6.  A second kindred linked to DFNA20 (17q25.3) reduces the genetic interval.

Authors:  A T DeWan; A R Parrado; S M Leal
Journal:  Clin Genet       Date:  2003-01       Impact factor: 4.438

7.  Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II.

Authors:  Michael D Weston; Mirjam W J Luijendijk; Kurt D Humphrey; Claes Möller; William J Kimberling
Journal:  Am J Hum Genet       Date:  2004-01-20       Impact factor: 11.025

Review 8.  Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy.

Authors:  David S Williams
Journal:  Vision Res       Date:  2007-10-23       Impact factor: 1.886

9.  USH1G with unique retinal findings caused by a novel truncating mutation identified by genome-wide linkage analysis.

Authors:  Faiqa Imtiaz; Khalid Taibah; Ghada Bin-Khamis; Shelley Kennedy; Amal Hemidan; Faisal Al-Qahtani; Khalid Tabbara; Bashayer Al Mubarak; Khushnooda Ramzan; Brian F Meyer; Mohammed Al-Owain
Journal:  Mol Vis       Date:  2012-07-12       Impact factor: 2.367

Review 10.  Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.

Authors:  Michelle L Hastings; John V Brigande
Journal:  Hear Res       Date:  2020-03-05       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.